Clinical Microbiology & Infection

Infectious causes of cancer: an evolving educational saga
pp. 961-963(3)
Author: Pappas, G.

Hepatitis B and C virus-related carcinogenesis
pp. 964-970(7)
Authors: Fung, J.; Lai, C.-L.; Yuen, M.-F.

Helicobacter pylori and gastric adenocarcinoma
pp. 971-976(6)
Authors: Herrera, V.; Parsonnet, J.

Human papilloma viruses and cancer in the post-vaccine era
pp. 977-981(5)
Authors: Galani, E.; Christodoulou, C.

Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma
pp. 982-988(7)
Authors: Shah, K. M.; Young, L. S.

A preventable killer: Pneumonia: World Pneumonia Day, 2 November 2009
pp. 989-990(2)
Authors: Klugman, K. P.; Garau, J.

Characterization of invasive isolates of Streptococcus pneumoniae among Taiwanese children
pp. 991-996(6)
Authors: Hsieh, Y.-C.; Huang, Y.-C.; Lin, H.-C.; Ho, Y.-H.; Chang, K.-Y.; Huang, L.-M.; Hsueh, P.-R.

Changes in serotypes causing invasive pneumococcal disease (2005-2007 vs. 1997-1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine
pp. 997-1001(5)
Authors: Salleras, L.; Domínguez, A.; Ciruela, P.; Izquierdo, C.; Navas, E.; Torner, N.; Borras, E.

Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine
pp. 1002-1007(6)
Authors: Sá-Leão, R.; Nunes, S.; Brito-Avô, A.; Frazão, N.; Simões, A. S.; Crisóstomo, M. I.; Paulo, A. C. S.; Saldanha, J.; Santos-Sanches, I.; de Lencastre, H.

Adult invasive pneumococcal disease between 2003 and 2006 in North-Rhine Westphalia, Germany: serotype distribution before recommendation for general pneumococcal conjugate vaccination for children <2 years of age
pp. 1008-1012(5)
Authors: Imöhl, M.; Reinert, R. R.; van der Linden, M.

Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain
pp. 1013-1019(7)
Authors: Guevara, M.; Barricarte, A.; Gil-Setas, A.; García-Irure, J. J.; Beristain, X.; Torroba, L.; Petit, A.; Polo Vigas, M. E.; Aguinaga, A.; Castilla, J.

Procalcitonin kinetics in Legionella pneumophila pneumonia
pp. 1020-1025(6)
Authors: de Jager, C. P. C.; de Wit, N. C. J.; Weers-Pothoff, G.; van der Poll, T.; Wever, P. C.

Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia
pp. 1026-1032(7)
Authors: Hohenthal, U.; Hurme, S.; Helenius, H.; Heiro, M.; Meurman, O.; Nikoskelainen, J.; Kotilainen, P.

Aetiology of, and risk factors for, recurrent community-acquired pneumonia
pp. 1033-1038(6)
Authors: Garcia-Vidal, C.; Carratalà, J.; Fernández-Sabé, N.; Dorca, J.; Verdaguer, R.; Manresa, F.; Gudiol, F.

High prevalence of multidrug-resistant Pneumococcal molecular epidemiology network clones among Streptococcus pneumoniae isolates from adult patients with community-acquired pneumonia in Japan
pp. 1039-1045(7)
Authors: Imai, S.; Ito, Y.; Ishida, T.; Hirai, T.; Ito, I.; Maekawa, K.; Takakura, S.; Iinuma, Y.; Ichiyama, S.; Mishima, M.

Clinical response to ertapenem in severe community-acquired pneumonia: a retrospective series in an elderly population
pp. 1046-1050(5)
Authors: Murcia, J. M.; González-Comeche, J.; Marín, A.; Barberán, J.; Granizo, J. J.; Aguilar, L.; González-Moreno, J.; González-Pina, B.; López-Dupla, M.; Irurzun, J.